Heart Vessels and Transplantation最新文献

{"title":"Algorithm of surgical tactics and surgical treatment of cholelithiasis complicated by multiple choledocholithiasis","authors":"M. Aimagambetov, Aldiyar Masalov, T. Bulegenov, Umitgul Ulan, Azhar Sarsembayeva, Meruert Nasikhatkyzy, Laura Turysbekova, N. Omarov, Medet Auyenov, S. Abdrakhmanov, Gulmira Akzhigitova","doi":"10.24969/hvt.2022.328","DOIUrl":"https://doi.org/10.24969/hvt.2022.328","url":null,"abstract":"Objective: Biliary stone disease is now one of the most common diseases, affecting 10-20% of the world's population. One of the most important problems in biliary tract surgery is the treatment of choledocholithiasis, which occurs in 10 to 38% of biliary stone disease according to different authors.\u0000\u0000Our research has allowed us to outline the most rational ways of treating patients in modern conditions. In our research, we focus on “the golden mean'” - a combination of staged minimally invasive interventions and standard interventions. Aim of our study was to evaluate the results of postoperative complications using the developed algorithm of surgical tactics and choledochoduodenoanastomosis from a minimally invasive approach.\u0000\u0000Methods: Overall,  35 patients who underwent surgical treatment of  cholelithiasis, cholangitis, benign genesis obstructive jaundice (BGOJ) were included to the study.\u0000\u0000All patients were divided into two groups (main group and comparison group) depending on the method of treatment used.   The study group consisted of 17 (48.6%) patients who underwent bile outflow restoration of choledochal outflow obstruction of the terminal section (choledochodenoanastamosis according to the developed by us  procedure (Kazakhstan patent №108142, Algorithm of diagnostics and surgical treatment tactics of benign genesis obstructive jaundice - Author's certificate № 24754. Control group consisted of 18 (51.4%) patients who underwent cholecystectomy, choledocholithiasis by Jurash-Vinogradov and applied conventional algorithm of diagnostics and treatment of multiple choledocholithiasis with benign genesis obstructive jaundice. We assessed complications of procedures according to Clavien-Dindo  and pain intensity level using visual analog score in both groups.\u0000\u0000Results:  When using the proposed algorithm and new methods of surgical treatment in patients in the study group the rate of complication was lower in the study group as compared to control group (p=0.04): there was no deficiency and bleeding from the anastomosis, while in control group they  turned out to be in 1 case. Complications in the form of seroma in 2 cases and bleeding into the subcutaneous tissue of the postoperative wound were in 1 case, being the same as in control group. No mortality was recorded in any group. The pain level was lower in the study group as compared to control group (p<0.05).\u0000\u0000Conclusions: Thus, the application of our algorithm for the diagnosis and surgical tactics of treatment of obstructive jaundice of benign genesis makes it possible to determine the tactics of surgical treatment of patients with obstructive jaundice.\u0000\u0000The developed technique for the surgical treatment of choledocholithiasis in cholelithiasis ensures the restoration of bile outflow in the duodenum, normalizes its morphofunctional state, prevents the development of various postoperative complications, in particular, there was no leakage and bleeding from the choledochoduodenoanastomosis i","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"47 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73508041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From Editor-in-Chief: Jubilee issue, 5-year gains and goals, important news from recent meetings and pandemics","authors":"G. Kudaiberdieva","doi":"10.24969/hvt.2022.326","DOIUrl":"https://doi.org/10.24969/hvt.2022.326","url":null,"abstract":"","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87517734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Stroke-associated in-hospital mortality","authors":"E. Mamytova, T. Maanaev, Dariha Bakaeva, Kh. E. Musaeva","doi":"10.24969/hvt.2022.323","DOIUrl":"https://doi.org/10.24969/hvt.2022.323","url":null,"abstract":"In this article, we narrated the epidemiological indicators of stroke in the world and in Kyrgyzstan as well. The data on morbidity, mortality and hospital mortality in acute cerebrovascular events, such as ischemic, hemorrhagic strokes, were shared.\u0000","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"35 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82662414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Insights from the EACVI document on multi-modality imaging assessment of native valvular regurgitation: what does it add to the ESC guidelines on the management of valvular heart disease?","authors":"Giuseppe Luliano, R. Citro","doi":"10.24969/hvt.2022.322","DOIUrl":"https://doi.org/10.24969/hvt.2022.322","url":null,"abstract":"European Association of Cardiovascular Imaging (EACVI) and European Society of Cardiology (ESC) council of valvular heart disease (VHD) have recently published a position paper on multi-modality imaging (MMI) assessment of native valvular regurgitation (1). The growing availability of devices and therapeutic techniques in recent years has enabled the treatment of increasingly complex valve disease. The opportunity to integrate data from different non-invasive imaging techniques allows a more precise morphologic and functional characterization of the disease and consequently the choice of the most appropriate therapeutic option. The purpose of this EACVI document is to complement the ESC 2021 guidelines on VHD by providing clinical guidance for the evaluation of native valve regurgitation by MMI (2).","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"86 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82018617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"European and American guidelines for the management of patients with heart failure - different recommendations based on the same research results?","authors":"A. Stańczyk","doi":"10.24969/hvt.2022.319","DOIUrl":"https://doi.org/10.24969/hvt.2022.319","url":null,"abstract":"Currently, the main reasons for significant changes in medical guidelines are new results of randomized clinical trials. In addition to the direct impact on the treatment of individual patients, the solutions proposed in the guidelines correlate with the decisions of health care payers in individual countries, and this largely translates into the overall quality of medical care. Considering the importance of guidelines of scientific societies, they must be comprehensive, objective, and at the same time, due to the constant technological and pharmacological progress, it is necessary to develop mechanisms thanks to which these guidelines can be regularly updated as new clinical data become available. The guidelines of the European Society of Cardiology (ESC) (1) and the joined guidelines of the American College of Cardiology Foundation (ACCF)/ American Heart Association (AHA)/ Heart Failure Society of America (HFSA) (2) for the management of patients with heart failure are particularly important due to their global reach. The authors of both documents restated both the definition of HF itself and novel pharmacological and non-pharmacological interventions. While the definition of the disease entity and general assumptions seem universal, the detailed treatment regimens differ (Table 1). The current classification of HF is as follows: HFrEF (HF with reduced ejection fraction (EF)): LVEF ≤40%; HFmrEF (HF with mildly reduced EF): LVEF 41-49%; HFpEF (HF with preserved EF): LVEF ≥50%. According to American guidelines we can distinguish also HFimpEF (HF with improved EF): previous LVEF ≤40% and followup measurement of LVEF >40%; and four stages of progression HF from A to D (At risk for HF -> Pre-HF -> symptomatic HF -> Advanced HF), with independent recommendations for each of them. Both publications indicate in the group of patients with HFrEF a 4-drug treatment regimen based on: 1) drugs affecting the renin-angiotensin-aldosterone system (RAAS): angiotensin converting enzyme inhibitor (ACEI), angiotensin II receptor blocker (ARB), angiotensin receptor neprilysin inhibitor (ARNI), 2) B-blockers (BB), 3) mineralocorticoid receptor antagonists (MRA), 4) sodium glucose cotransporter-2 inhibitors (SGLT2i), which is becoming a major player in the treatment of heart failure. The ACCF/AHA/HFSA guidelines strongly identify ARNI as the preferred RAAS modulator with a class Ia recommendation and state that the use of ACEI or ARB may be used \"when the use of ARNI is not possible.\" The ESC guidelines appear to be more conservative, establishing the strength of the recommendations for the use of ARNI as Ib, stating that ARNI is recommended \"as a replacement for angiotensin converting enzyme inhibitors\" in suitable patients who remain symptomatic despite optimal treatment, although ARNI can be considered a first-line drug (class IIb). There is no differences in recommendation of loop diuretics (class I), ivabradine (class IIa), verciguat (class IIb) or digoxin (clas","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86653034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The missed chance you'll never regret: a predator journal's invitation","authors":"Luigi Spadafora, Adelaide Iervolino, G. Biondi-Zoccai","doi":"10.24969/hvt.2022.320","DOIUrl":"https://doi.org/10.24969/hvt.2022.320","url":null,"abstract":"Luigi Spadafora, Adelaide Iervolino, Giuseppe Biondi-Zoccai 3,4 Department of Clinical, Internal Medicine, Anesthesiology and Cardiovascular Sciences, Sapienza University of Rome, Italy Department of Clinical Medicine and Surgery, Federico II University, Naples, Italy Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy Mediterranea Cardiocentro, Napoli, Italy","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"328 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-06-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73752898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiofrequency ablation of the left atrial scar-related atrial flutter in a patient without prior ablative procedures","authors":"A. Sergeev, A. Akhobekov, D. Koblov, A. Turdubaev","doi":"10.24969/hvt.2022.327","DOIUrl":"https://doi.org/10.24969/hvt.2022.327","url":null,"abstract":"Atypical atrial flutter may develop in patients without prior cardiac ablations. In such cases, they may be related to the areas of spontaneous left atrial scarring. We describe a case report of a patient with atypical left atrial flutter with areas of spontaneous left atrial scarring adjacent to the mitral valve annulus.\u0000","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"21 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86035983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Device Therapy Recommendations In Recent Heart Failure Guidelines: A Closer Look","authors":"O. Baysan, İ. Akyıldız","doi":"10.24969/hvt.2022.318","DOIUrl":"https://doi.org/10.24969/hvt.2022.318","url":null,"abstract":"Recent guidelines released by two sides of Atlantic (1, 2) provide a general roadmap for medical community dealing with heart failure management. In these guidelines heart failure patients are classified according to their ejection fraction (EF) values: Heart Failure with Preserved EF (HFpEF), Heart Failure with Mildly Reduced EF (HFmrEF) and Heart Failure with Reduced EF (HFrEF). Non-pharmacological and pharmacological treatment options are recommended in these guidelines in relevant sections pertaining to heart failure subgroups. Device therapy is mainly restricted to HFrEF patients due to clinical data obtained from this heart failure subgroup. We aimed to highlight two guideline’s similarities and differences in device therapy recommendations for a busy clinician.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91128955","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Perspectives of ACC/AHA/SCAI myocardial revascularization 2022 guideline implementation in Kyrgyz Republic","authors":"A. Toktosunova, M. Beishenkulov","doi":"10.24969/hvt.2022.317","DOIUrl":"https://doi.org/10.24969/hvt.2022.317","url":null,"abstract":"In the Kyrgyz Republic, 52% of all deaths are due to cardiovascular diseases, of which 2/3 is coronary artery disease (CAD) (1). The implementation of the ACC/AHA/SCAI Guideline for Coronary Artery Revascularization 2022 (2) is a necessary objective. This Guideline is the result of joint work of the American Heart Association, the American College of Cardiology and Society for Cardiovascular Angiography and Interventions (2). These recommendations are based on recent randomized clinical trials with a high-degree of evidence. However, their full implementation is hampered by local problems in equipment and skills. Unfortunately, the government does not provide the patients with consumables for coronary angiography, balloon angioplasty and stenting. Everything is purchased at their own expense. Therefore, primary percutaneous coronary interventions (PCI) is not performed in all the regions of the Kyrgyz Republic. The next reason for the difficulty in introducing primary PCI is the availability of a catheter laboratory in only three cities of the country. In four out of seven regions, there is no angiographic facility at all. In this regard, the main approach for the treatment of acute myocardial infarction with ST-segment elevation (STEMI) is thrombolytic therapy. In a small proportion of patients in cities where there is a catheter laboratory, a pharmaco-invasive reperfusion method is used. The situation is especially bad with the treatment of STEMI in the presence of pulmonary edema, cardiogenic shock. In this category of patients, PCI is challenging due to the lack of experience, absence of intra-aortic balloon pump and other means of mechanical circulatory support. Another problem is that in stable patients with acute myocardial infarction, if PCI is performed, then coronary artery bypass grafting is not performed in all cases with indication. After reviewing the clinical guidelines, we would like to note the recommendations that can be put into practice right now. The implementation of Heart Team approach Recommendations: In patients for whom the optimal treatment strategy is unclear, a Heart Team approach that includes representatives from interventional cardiology, cardiac surgery, and clinical cardiology is recommended to improve patient outcomes (I, B-NR). -The implementation of SYNTAX, STS scores Recommendations: In patients with multivessel CAD, an assessment of CAD complexity, such as the SYNTAX score, may be useful to guide revascularization (2b, BNR). -The implementation of physiological methods of assessing lesion significance fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR). Recommendations: In patients with angina or an anginal equivalent, undocumented ischemia, and angiographically intermediate stenoses, the use of FFR or iFR is recommended to guide the decision to proceed with PCI (1, A). In stable patients with angiographically intermediate stenoses and FFR >0.80 or iFR >0.89, PCI should not be performed (3, ","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87670197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy","authors":"Ulises Rojel, I. Lopez, Carlos de la Fuente, Erick Gomez, A. Enríquez, Sandra Maldonado","doi":"10.24969/hvt.2022.316","DOIUrl":"https://doi.org/10.24969/hvt.2022.316","url":null,"abstract":"Paroxysmal supraventricular tachycardias during pregnancy are rare; however, it can be a therapeutic challenge because of limitations about use of antiarrhythmic drug therapy and catheter ablation indication, due to the risk of radiation exposure to the fetus and the mother. We present the case of a pregnant woman with Wolf-Parkinson-White syndrome with recurrent episodes of tachycardia, refractory to antiarrhythmic drug therapy, who underwent catheter ablation of a left lateral accessory pathway without the use of fluoroscopy.","PeriodicalId":32453,"journal":{"name":"Heart Vessels and Transplantation","volume":"22 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-05-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78719320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}